Jin Zhang

Associate Director of Business Development

2023 - 2024

Sourced more than 150 potential partnering opportunities and moved more than 60 of them into in-depth due diligence annually ● Led and coordinated cross-functional teams, including scientific, clinical, commercial, regulatory, financial, legal experts, etc. to conduct DD and drive decisions on more than 15 deals annually ● Experienced with formulating documents and presentations to convince the partnering case to senior management and shareholders and get them on board ● Collaborated with transaction lead and supported term sheet and contract review and revision on more than 15 deals annually ● Strong end-to-end deal experience in licensing drug candidates in various stages of development: the USP1 deal between Exelixis and Insilico Medicine, achieving the exclusive global right to its development and commercialization with an $80M upfront payment ● Proactively analyzed the oncology market, identified promising drug targets and formats to target, and provided insights/recommendations to senior management teams ● Strong knowledge of the oncology landscape, including targets and modalities, emerging science, drug discovery and development processes, industry trends, and competitive environment ● Actively cultivated strong relationships with different shareholders and teams to ensure effective communication and coordination among them ● Built strong relationships with other pharma BDs, VCs, universities, institutions, entrepreneurs, startups, and KOLs in both the US and Asia to identify BD opportunities

Investor

2018 - 2023

• Strong domain knowledge in life science, including oncology, immunology, neuroscience, diagnostics, genomics, proteomics, medical device, etc. • Actively analyzed market trends and identified gene therapy, multiomics, autoimmune diseases, neuroscience as hot and fast growing market opportunities to invest • Lead the search and evaluation of potential investment targets and conducted full DD on their market potential, competitive landscape, technology innovation, market position, clinical development, regulation, and commercial potential • Built investment cases to persuade investment decisions and eventually led the investment into Angarus Therapeutics, Lassogen, etc. • Led and developed effective deal structure, risk mitigation, and negotiation strategies to secure the most favorable and reasonable terms for both sides • Actively review and monitor portfolio companies by keeping abreast of their developments, building and maintaining good working relationships with executive management and the Board, and participating in Board meetings • Currently a board member of 5 companies, including Angarus Therapeutics, Avotres Therapeutics, CouraGene, etc. • Support portfolio companies in fundraising/BD by generating storylines, decks, deal comps, financial projections, timelines, and potential questions, along with providing a list of investors, conducting investor outreaches, keeping track of fundraising status, and generating feedback • Built strong relationships with other life science VCs, pharma companies, universities, institutions, entrepreneurs, startups, and KOLs in both US and Asia to identify investment targets early on and bring in funding for portfolio companies • Experienced with formulating documents and presentations to convince investment cases to both internal and external shareholders and get them on board • Regularly participated in various conferences as pitch judges or speakers to talk about new development in the life science and VC industry

Editor

2016 - 2018

Provide insights and advise on the Chinese pharmaceutical industry and its investment market https://www.pharmexec.com/authors/jin-zhang-md-phd

Account Manager

2017 - 2018

• Developed relationships with more than 300 customers and brought in more than 30 projects quarterly • Generated new marketing campaigns and improved the CTR by 20% and the revenue by 15% for 2018

Project Manager

2016 - 2018

• Manage more than 30 projects quarterly through the individualized account management approach and successfully deliver results • Consistently generate new sales and bring in more than 20 new projects per quarter by cultivating relationships with existing and new clients • Developed new marketing campaigns, improved website’s organic traffic, and raised Google AdWords’ performance, thus increased CTR by 20% and revenue by 15% for 2017 • Skilled in conducting competition studies to understand market trends and competitors’ positions to guide future product developments • Initiated multiple strategies to improve company’s efficacy and efficiency

Director of Business Development

2016 - 2017

Independent consultant

2016 - 2016

• Conducted market research to analyze the value position of various immunological drug targets for cancer therapies • Developed strategies to optimize drug efficacy and defined market opportunities

Board Member

2015 - 2016

• Collaborated with Vice Chancellor, staff representatives, and faculty representatives on multiple events to increase the health awareness across the campus and successfully initiated the Diabetes Prevention program • Assisted in the initiation and development of the UC Global food Initiative Project and Food Day event

Co Founder

2014 - 2016

• Founded a student group to promote science to the general population • Invited 15 professors as advisors and led a number of multi-topic events attended by more than 100 students • Presented in five meetings to the general population and undergraduate students. • Successfully grew the membership to over 150

Graduate Student Researcher

2012 - 2016

• Experienced in cardiology, immunology, aging, and cancer researches. • Presented in six international conferences to more than 100 attendees and three meetings to educate physicians at the UCLA Ronald Regan hospital. • Discovered new BK channel interacting targets and developed a novel in-vivo model for research on mitochondrial protein import • Prepared "BK Channel Subproteome Reveals its Interaction with ADP/ATP Translocase and Hints on its Mitochondrial Import Mechanism” for publication • Collaborated with multiple lab members leading to two peer reviewed publications • Managed and mentored 4 undergraduate students in experiment design and delivery • Related Business Coursework: Venture Initiation and Entrepreneurship, Accounting, Business strategy, Leadership and Managerial communication

Team Lead

2016 - 2016

• Won the second place as the only non-MBA team out of 16 MBA teams • Led a team of multidisciplinary experts working with a non-profit company and developed a business model to increase its revenue by $21,000 annually and serve 35% more patients

President

2015 - 2016

• Grew club membership from 100 to 200 students • Led a team of 12 members working with non-profits on the Bruin Shelter Project and helped them improved the infrastructure, developed a business plan, and secured a funding of $25,000 • Established strong relationships with multiple consulting companies and professional organizations, including L.E.K., BCG, Oystir, BCLA, and Scicomm

Team Lead

2015 - 2016

• Led a team of multidisciplinary experts and conducted IP assessment on a cutting-edge technology, mapping out its market position and value proposition, and wrote a concrete business plan